0001014108-23-000032.txt : 20230213
0001014108-23-000032.hdr.sgml : 20230213
20230213122152
ACCESSION NUMBER: 0001014108-23-000032
CONFORMED SUBMISSION TYPE: 5
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221231
FILED AS OF DATE: 20230213
DATE AS OF CHANGE: 20230213
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ugwumba Chidozie
CENTRAL INDEX KEY: 0001835544
FILING VALUES:
FORM TYPE: 5
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39834
FILM NUMBER: 23616110
MAIL ADDRESS:
STREET 1: 158 FILMORE STREET
CITY: DENVER
STATE: CO
ZIP: 80206
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Clene Inc.
CENTRAL INDEX KEY: 0001822791
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 852828339
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6550 SOUTH MILLROCK DRIVE, SUITE G50
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84121
BUSINESS PHONE: 801-676-9695
MAIL ADDRESS:
STREET 1: 6550 SOUTH MILLROCK DRIVE, SUITE G50
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84121
FORMER COMPANY:
FORMER CONFORMED NAME: Chelsea Worldwide Inc.
DATE OF NAME CHANGE: 20200827
5
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
5
2022-12-31
0
0
1
0001822791
Clene Inc.
CLNN
0001835544
Ugwumba Chidozie
609 SW 8TH STREET, SUITE 365
BENTONVILLE
AR
72712
1
0
0
0
Common Stock
2022-12-31
4
J
0
L
1019210
0
A
5548019
I
By SymBiosis II, LLC
The shares are directly held by SymBiosis II, LLC. Amount reflects an additional 1,019,210 shares located in a separate brokerage account during the issuer's fiscal year.
/s/Chidozie Ugwumba
2023-02-10